Shweta Sharma

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

Thomas L Holland, Adit A. Ginde, Roger Paredes et al. · The Lancet Respiratory Medicine · 2022 · 128 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +4

Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance

Edward M. Gardner, Shweta Sharma, Grace Peng et al. · AIDS · 2008 · 125 citations

Pharmacy, Pharmacotherapy, Hiv Control +15

Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial

Jason V. Baker, Shweta Sharma, Birgit Grund et al. · Open Forum Infectious Diseases · 2017 · 87 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV‐Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial

Jason V. Baker, Shweta Sharma, Amit C. Achhra et al. · Journal of the American Heart Association · 2017 · 74 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Antiretroviral medication adherence and class-specific resistance in a large prospective clinical trial

Edward M. Gardner, Katherine Huppler Hullsiek, Edward E. Telzak et al. · AIDS · 2010 · 67 citations

Life Sciences, Pharmacotherapy, Hiv Control +16